Ceredex Value Advisors’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-82,000
Closed -$21M 169
2025
Q3
$21M Buy
+82,000
New +$20.6M 0.49% 81
2025
Q2
Sell
-343,618
Closed -$83.7M 176
2025
Q1
$83.7M Buy
343,618
+238,318
+226% +$59.9M 1.83% 3
2024
Q4
$26.8M Buy
+105,300
New +$28.2M 0.54% 77
2024
Q3
Sell
-350,356
Closed -$84.9M 164
2024
Q2
$84.9M Buy
350,356
+196,106
+127% +$46.8M 1.61% 11
2024
Q1
$41.3M Sell
154,250
-233,782
-60% -$59.5M 0.72% 57
2023
Q4
$96M Sell
388,032
-164,651
-30% -$33.4M 1.66% 10
2023
Q3
$101M Buy
552,683
+403,208
+270% +$82.3M 1.79% 12
2023
Q2
$35.2M Sell
149,475
-45,550
-23% -$9.59M 0.57% 70
2023
Q1
$39.6M Buy
195,025
+3,450
+2% +$718K 0.62% 66
2022
Q4
$37.2M Buy
+191,575
New +$35M 0.57% 63

Other funds holding EFX

Ceredex Value Advisors's EFX Position: Q4 2025 in Review

Ceredex Value Advisors sold out of Equifax (EFX) in Q4 2025, closing a stake of 82,000 shares — an estimated $21M sold.

Ceredex Value Advisors first reported a position in EFX in Q4 2022 and held it in 10 quarters. The position peaked at $101M in Q3 2023. 895 funds tracked by Wall St. Rank hold EFX as of Q4 2025.

  • Ceredex Value Advisors reported no remaining Equifax position as of Q4 2025 after selling out during the quarter.
  • Ceredex Value Advisors sold 82,000 Equifax shares in Q4 2025, an estimated $21M.
  • Ceredex Value Advisors first reported a position in Equifax in Q4 2022 and held it in 10 quarters.
  • Ceredex Value Advisors's Equifax position peaked at $101M in Q3 2023.
  • 895 funds tracked by Wall St. Rank held Equifax as of Q4 2025.

Based on Ceredex Value Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.